Account
OMD India bags HTC’s Rs 400-450 million worth media duties
Indiantelevision.com and Spatial Access Solutions‘ newsletter — ‘Ad Accounts Action‘ — that will keep you abreast with all the creative and media accounts changing hands in the industry. Spatial Access Solutions (SAS) is India‘s first media audit firm and hence, has a keen eye on all movements in the space. ‘Ad Accounts Action‘ is brought to you once every fortnight. Given below is a listing of accounts that moved in the period 01 September 2011 – 14 September 2011. |
Account name | Incumbent | New agency | Reported annual spends in Rs |
| Media | |||
| Formula 1 Track [Jaypee Sports International] | Lodestar UM | 250-300 million | |
| Gufic Biosciences Ltd [GBSL] | MPG India | NA | |
| HTC | OMD [Delhi] | 400-450 million | |
| PolicyBazaar.com | Lintas Media Group | Maxus India | 220-250 million |
| Tourism Australia | Carat | OMD India | 130-150 million |
Creative | |||
| BIG RTL [Upcomming Channels] | Salt Brand Solutions | NA | |
| Carlsberg | OPercept/H | Saatchi & Saatchi | NA |
| Daiki Brands | Percept/H | NA | |
| Formula 1 Track [Jaypee Sports International] | Tag | 250-300 million | |
| Maxo | Rediffusion [Bangalore] | Mudra [Mumbai] | NA |
| Exo | Mudra [Bangalore] | Mudra [Mumbai] | |
| Pril | TBWA [Mumbai] | ||
| MEN & BOYS [Retail] | Plan B | NA | |
| Moneycontrol.com | Contract Advertising | 200 million | |
| Rebirth | Network Advertising | Saatchi & Saatchi Health [Mumbai] | NA |
| Evolve Medspa | |||
| Birla Kerela Vaidyashala | |||
| Siyaram‘s | IBD | Makani Creatives [Mumbai] | NA |
| J Hampstead | |||
Creative & Media | |||
| Ambience Mall | Brand Curry | 60-70 million | |
| Orient Home Appliance Business | Triton Comminications [Delhi] | 150 million | |
| Information compiled for period 01 Sep 2011 – 14 Sep 2011. by Spatial Access Media Solutions, India‘s first Media Audit & Advisory. For information or clarifications email : info@spatialaccess.com, www.spatialaccess.com | |||
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
